Cargando…
P909: POMALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE CHEMOTHERAPY FOR NEWLY DIAGNOSED MULTIPLE MYELOMA: POMACE PHASE II STUDY
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430909/ http://dx.doi.org/10.1097/01.HS9.0000970540.51359.60 |
_version_ | 1785091072560463872 |
---|---|
author | Saj, Fen Nisha, Yadav Ganesan, Prasanth Kayal, Smita Kar, Rakhee Halanaik, Dhanapathi Dubashi, Biswajit |
author_facet | Saj, Fen Nisha, Yadav Ganesan, Prasanth Kayal, Smita Kar, Rakhee Halanaik, Dhanapathi Dubashi, Biswajit |
author_sort | Saj, Fen |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10430909 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104309092023-08-17 P909: POMALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE CHEMOTHERAPY FOR NEWLY DIAGNOSED MULTIPLE MYELOMA: POMACE PHASE II STUDY Saj, Fen Nisha, Yadav Ganesan, Prasanth Kayal, Smita Kar, Rakhee Halanaik, Dhanapathi Dubashi, Biswajit Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430909/ http://dx.doi.org/10.1097/01.HS9.0000970540.51359.60 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Saj, Fen Nisha, Yadav Ganesan, Prasanth Kayal, Smita Kar, Rakhee Halanaik, Dhanapathi Dubashi, Biswajit P909: POMALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE CHEMOTHERAPY FOR NEWLY DIAGNOSED MULTIPLE MYELOMA: POMACE PHASE II STUDY |
title | P909: POMALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE CHEMOTHERAPY FOR NEWLY DIAGNOSED MULTIPLE MYELOMA: POMACE PHASE II STUDY |
title_full | P909: POMALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE CHEMOTHERAPY FOR NEWLY DIAGNOSED MULTIPLE MYELOMA: POMACE PHASE II STUDY |
title_fullStr | P909: POMALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE CHEMOTHERAPY FOR NEWLY DIAGNOSED MULTIPLE MYELOMA: POMACE PHASE II STUDY |
title_full_unstemmed | P909: POMALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE CHEMOTHERAPY FOR NEWLY DIAGNOSED MULTIPLE MYELOMA: POMACE PHASE II STUDY |
title_short | P909: POMALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE CHEMOTHERAPY FOR NEWLY DIAGNOSED MULTIPLE MYELOMA: POMACE PHASE II STUDY |
title_sort | p909: pomalidomide, bortezomib, and dexamethasone chemotherapy for newly diagnosed multiple myeloma: pomace phase ii study |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430909/ http://dx.doi.org/10.1097/01.HS9.0000970540.51359.60 |
work_keys_str_mv | AT sajfen p909pomalidomidebortezomibanddexamethasonechemotherapyfornewlydiagnosedmultiplemyelomapomacephaseiistudy AT nishayadav p909pomalidomidebortezomibanddexamethasonechemotherapyfornewlydiagnosedmultiplemyelomapomacephaseiistudy AT ganesanprasanth p909pomalidomidebortezomibanddexamethasonechemotherapyfornewlydiagnosedmultiplemyelomapomacephaseiistudy AT kayalsmita p909pomalidomidebortezomibanddexamethasonechemotherapyfornewlydiagnosedmultiplemyelomapomacephaseiistudy AT karrakhee p909pomalidomidebortezomibanddexamethasonechemotherapyfornewlydiagnosedmultiplemyelomapomacephaseiistudy AT halanaikdhanapathi p909pomalidomidebortezomibanddexamethasonechemotherapyfornewlydiagnosedmultiplemyelomapomacephaseiistudy AT dubashibiswajit p909pomalidomidebortezomibanddexamethasonechemotherapyfornewlydiagnosedmultiplemyelomapomacephaseiistudy |